Nifty hit record highs on vaccine progress

  • Reuters
  • Stock Market News
Nifty hit record highs on vaccine progress

By Chris Thomas

BENGALURU, Dec 9 (Reuters) - Indian shares touched a record high on Wednesday, driven by gains in heavyweight Reliance Industries , as hopes for vaccine approvals in the second worst coronavirus-hit country boosted investor sentiment.

The NSE Nifty 50 index .NSEI rose 0.69% to 13,485.75 by 0446 GMT and was headed for a seventh consecutive session of gains, while the benchmark S&P BSE Sensex .BSESN was up 0.72% at 45,938.47. Both have hit record highs in 14 of the last 21 sessions and are up 4% so far in December.

India's federal health secretary said on Tuesday the country may approve some coronavirus vaccines over the next few weeks and an estimated 300 million people would be inoculated in the first tranche. has the world's second-highest virus caseload behind the United States, but daily cases have stayed below the 50,000-mark since Nov. 8, despite a busy festival season that saw crowded markets and streets. vaccine news is a sentiment booster. But it is gushing liquidity that is supporting markets, we are seeing risk-on sentiment building up globally," said Aishvarya Dadheech, fund manager at Ambit Asset Management in Mumbai.

"I believe markets will see traction building over the next 1-1/2 to two years as the economy recovers from the pandemic," Dadheech said.

Consumer goods giant ITC Ltd ITC.NS climbed 2.3% to its highest since Aug. 11, while index heavyweight Reliance Industries Ltd (NS: RELI ) added 1.1% and top private-sector lender HDFC Bank Ltd HDBK.NS rose nearly 1%.

Prestige Estates Ltd PREG.NS rose as much as 4.6% after India's competition regulator approved https://twitter.com/CCI_India/status/1336281154635239426?s=20 the acquisition of some Prestige assets by affiliates of Blackstone (NYSE: BX ) Group.

Global equities traded higher on Wednesday, after Britain started mass-vaccinating its people using a fully-tested COVID-19 shot and as Johnson & Johnson (NYSE: JNJ ) JNJ.N said it could obtain late-stage trial results for a single-dose vaccine earlier than expected. MKTS/GLOB

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100
  • Rakesh Prasad @Rakesh Prasad
    Too high to take trade. Better let nifty take a correction.
    Like 0
  • dumb fuk @dumb fuk
    nifty hit record high , due to liquidity tap
    Like 0

Related Articles